Attunement AI

• Requires deep EHR write-back integrations immediately and Attunement cannot provide them.
• Requires SOC 2 Type II or ISO 27001 as a strict procurement requirement.
• Seeks fully autonomous diagnosis or hands-off clinical narrative generation.

• Vendor materials indicate caution around AI’s ability to diagnose and emphasize assistive use with clinicians remaining in the loop.

• A tools page on attunement.ai references forthcoming features without detailed timelines.

• Whether uploaded PHI is used for model training and under what opt-out/opt-in conditions
• Data retention, deletion, and backup policies
• Exact supported document formats and maximum sizes
• API availability and integration scope

• Citation-based provenance in drafts: the vendor emphasizes traceability back to source documents as a clinical safety and defensibility feature.
• Assessment-professional focus: explicit targeting of neuropsych/testing report workflows rather than generic clinical notes.

• Some competitors publicly present enterprise security attestations and deep EHR integrations, which are important for larger deployments.
• Established competitors are likely to have a larger third-party review footprint and more customer references.

For Attunement (vendor website) specifically:

• G2, TrustRadius, Gartner Peer Insights, and Capterra: No dedicated, accessible product listing and review corpus was found in the performed searches.

Implication: There is limited third-party review data publicly available for Attunement AI as of early March 2026, which is consistent with an early-stage product.

Searches for the vendor name surfaced discussion of the conceptual topic of attunement in AI behavior rather than product feedback. Example: a community discussion thread on AI behavioral modes referenced the concept but not the product.

Vendor pages include marketing claims that function like testimonials but lack named customer citations or independent verification:

• The vendor states that a sizable group of psychologists helped develop the platform.
• The vendor claims meaningful average time savings on drafting neuropsychology reports.

Critical note: These claims are not independently verified in accessible sources (no methodology, sample size, or case-study details were provided).

Vendor-authored material includes an internal experiment summary reporting modest diagnostic accuracy and a nontrivial misdiagnosis rate in a small internal sample. This is a vendor-published performance disclosure rather than a customer testimonial.

• Need for audit readiness and documentation consistency in behavioral health organizations
• Desire for citation-linked provenance in assessment-heavy report drafting
• Small practices seeking assistant-like support without hiring additional staff

• Lack of independently verified accuracy; clinicians may find drafts require substantial editing.
• Limited public security documentation may block enterprise adoption.
• Pricing opacity and services-heavy components (assistant matching) may feel less predictable than pure SaaS.

No formal customer case studies with named organizations, quantified outcomes, and implementation timelines were found in accessible sources for Attunement AI or Attunement Clinical.

• The vendor claims significant time savings on drafting neuropsychology reports.
• The vendor states that a substantial number of psychologists participated in platform development.

Methodology gaps: No clear explanation was provided for baseline time measurement, sample size, whether time saved includes human review time, or how savings vary by report type.

The vendor’s blog post shares an experiment comparing GPT-4 outputs to clinician labels across a modest number of cases, which showed roughly half agreement with clinician labels and a notable rate of misdiagnosis. This disclosure is concrete for a vendor blog but:

• It does not directly measure Attunement Notebook performance.
• Details such as prompt format, adjudication method, and dataset selection bias are not fully described.

Two plausible ICP bands based on messaging:

1. Solo to small-group testing practices (very small teams with a few clinicians, plus coordinators/psychometrists) that produce long neuropsych/testing reports and face report preparation time constraints.
2. Mid-sized behavioral health organizations with compliance and audit risk exposure and significant documentation volumes.

• Behavioral health
• Neuropsychology and psychological assessment clinics
• Specialty medicine teams handling assessment-heavy documentation

• Decision makers: clinical directors, practice owners, compliance leaders, operations directors
• End users: neuropsychologists, testing psychologists, psychometrists, clinical administrators

• Produces long, structured reports where source traceability is valued.
• Has repeatable workflows and templates that can be standardized.
• Willing to maintain clinician oversight for verification and final sign-off.